AUAUniversity cover art

All Episodes

AUAUniversity — 452 episodes

#
Title
1

AUA2026: Focus on: Non-Muscle Invasive Bladder Cancer Update for the Urology Care Team

2

Update Series (2026): Case Based Medical and Surgical Management of Peyronie's Disease

3

AUA2026: Contemporary Management of Advanced Prostate Cancer: Guidelines and Beyond

4

AUA2026: Focus on: Muscle Invasive Bladder Cancer

5

AUA2026: Focus on: ADT in the Modern Era

6

Innovations in the Surgical Management of BPH (2026)

7

Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach

8

AUA Guidelines: Advanced Prostate Cancer

9

AUA2026: Focus on: Metastatic Urothelial Carcinoma (mUC)

10

AUA Guidelines: Clinically Localized Prostate Cancer

11

Update Series (2026): Kidney Stones and the Infected Patient

12

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast

13

AUA2026 Spotlight: PARP-Inhibitor Combination Treatments for the Urologic Care Team

14

Update Series (2026) Lesson 15: Case-Based Testicular Cancer Clinical Practice Guidelines

15

AUA Guidelines: Management of Lower Urinary Tract Symptoms Attributed to BPH

16

AUA2026: Society of Women in Urology Meeting

17

AUA2026: Society of Urologic Oncology Meeting

18

AUA2026: Society of Benign Prostate Disease Meeting

19

AUA Guidelines: Early Detection of Prostate Cancer

20

AUA2026: Sexual Medicine Society of North America Meeting

21

AUA2026: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Meeting

22

Update Series (2026): At-Home Diagnostic and Therapeutic Options in Men's Health

23

AUA2026: Research Programming Preview: Amplifying the Impact of Research for Career Development

24

Update Series (2026): Perioperative Management of Urinary Diversion

25

AUA2026: Advanced Cystoscopy Training for APPs

26

LG-IR-NMIBC Treatment Landscape (Republished)

27

NMIBC Treatment Landscape (Republished)

28

MIBC Treatment Landscape (Republished)

29

AUA2025: Key Takeaways: Bladder Cancer

30

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications

31

Adjuvant Therapy for Renal Cell Carcinoma

32

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System

33

Update Series: The Role of Nephrectomy in Advanced Kidney Cancer

34

AI for Prostate Cancer Treatment Planning

35

AUA Guidelines: Salvage Therapy for Prostate Cancer

36

AUA Guidelines: Diagnosis and Management of Male Chronic Pelvic Pain

37

NMIBC Treatment Landscape

38

MIBC Treatment Landscape

39

AUA Guidelines: Genitourinary Syndrome of Menopause

40

LG-IR-NMIBC Treatment Landscape

41

Core Curriculum: Surgical Management of Urolithiasis

42

AUA2025: Key Takeaways: BPH

43

AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction

44

AUA Guidelines: Recurrent Uncomplicated Urinary Tract Infections in Women

45

Core Curriculum: Anorectal Malformation

46

AUA2025: Key Takeaways: Endourology/Stones Highlights

47

Update Series (2025) Lesson 30: Beyond Ureteropelvic Junction: Case-Based Tips and Tricks in Robotic Ureteral Stricture Reconstructive Surgery

48

The Latest Breakthroughs in LG-IR-NMIBC (2025)

49

The Latest Breakthroughs in mHSPC

50

AUA2025: Key Takeaways: Sexual Dysfunction Highlights

51

AUA2025: Key Takeaways: Female Urology Highlights

52

AUA2025: John Duckett Memorial Lecture: Obstructive Bladder Disease: Molecular Insights and Therapeutic Opportunities

53

AUA2025: Ramon Guiteras Lecture: The Future of Healthcare: How Will Urology be Impacted?

54

AUA2025: John K Lattimer Lecture: Telesurgery

55

Contemporary Management of MIBC and Beyond: Expert Guidance for Urologists (Republished)

56

AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)

57

Update Series (2025) Lesson 18: Multidisciplinary Evaluation and Management of Pelvic Pain in Women

58

AUA2025: Incorporating Genomic Testing and Advanced Imaging for Prostate Cancer Into Your Practice

59

AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

60

The Surgical Management of BPH (2025)

61

AUA2025: AUA Advanced Prostate Cancer Course

62

AUA2025: Should I Order a PET Scan? Integrating Molecular Imaging Into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities

63

AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm

64

AUA2025: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice

65

Highlights from AUA2025: Advances in NMIBC (2025)

66

AUA Guidelines: Microhematuria

67

AUA2025: Embracing Multi-Disciplinary Care for Advanced Prostate Cancer: A Case-Based Update 2025

68

AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them

69

AUA2025: Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer

70

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team

71

Live from AUA2025: Advances in ADT Program

72

AUA2025: Sexual Medicine Society of North America Meeting

73

AUA2025: Society of Urological Robotic Surgeons Meeting

74

AUA2025: Focal Therapy Society Meeting

75

Update Series 2025: Congenitalism: Transitioning Patients with Congenital Urological Anomalies

76

AUA2025: Masterclass: Renal Access and Interventions (2025)

77

Hereditary Kidney Cancer Syndromes (Republished)

78

AUA2025: Fundamentals of Prostate MRI and Transperineal Interventions (2025)

79

Recognition and Management of Complications Following Gender Affirming Surgery

80

AUA Guidelines: Diagnosis and Treatment of Infertility in Men

81

AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder

82

AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer

83

Biomarkers and Molecular Imaging for Prostate Cancer (Republished)

84

Appropriate Use of Genetic Testing (Republished)

85

Treatment Intensification in Metastatic HSPC (Republished)

86

Sequencing Of Agents (Republished)

87

Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists

88

Contemporary Management of MIBC and Beyond: Expert Guidance for Urologists

89

Complex Cases in Kidney Stone Disease

90

Update Series Lesson 39: Penile Duplex Doppler Ultrasound in the Evaluation of Sexual Dysfunction

91

AUA2024: Journal Of Urology Lecture

92

AUA2024: Ramon Guiteras Lecture

93

AUA Leadership and Business Podcast: Urology Practice Manage - Overcoming Operational Challenges

94

Core Curriculum: Focal Therapy Options for Prostate Cancer

95

Hereditary Kidney Cancer Syndromes

96

Prostate Cancer Update (2024): Expert Guidance for Urologists

97

Treatment Intensification in Metastatic HSPC

98

Appropriate Use of Genetic Testing (who, what, when and how?)

99

Sequencing Of Agents

100

Core Curriculum: Urologic Oncology: Genetics And Genomics

101

Biomarkers and Molecular Imaging for Prostate Cancer

102

Core Curriculum: Kidney Cancer & SBRT in the Management of RCC

103

Core Curriculum: Pediatric Urology: Differences of Sex Development

104

AUA2024:How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

105

AUA2024: The Changing Face of Advanced Prostate Cancer

106

Update Series (2024) Lesson 6: AUA Localized Renal Mass Guidelines Update

107

AUA2024: Prostate Cancer Diagnosis

108

AUA2024: Incorporating Genomic Testing and Advanced Imaging For Prostate Cancer Into Your Practice

109

AUA2024: Upper Tract Urothelial Cancer (UTUC) Guidelines

110

The Surgical Management of BPH and Updates from the AUA Clinical Guidelines

111

AUA2024: New AUA Guideline: Salvage Therapy for Prostate Cancer

112

AUA2024: Genetics and Genomics of Urological Cancers

113

AUA2024: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

114

AUA2024: Contemporary Pharmacotherapy for OAB 2024

115

AUA2024: AUA Advanced Prostate Cancer Guidelines

116

Live from AUA2024: Highlights in Bladder Cancer

117

AUA2024: Upper Tract Urothelial Carcinoma Tumor Board: A Case-Based Approach to Management

118

AUA2024: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

119

AUA2024: Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder

120

AUA2024: Genetics and Genomics of Urological Cancers

121

Core Curriculum: Journal Club 101

122

Core Curriculum: BPH: Surgical Treatment

123

AUA2024: Surgical Laser Enucleation of the Prostate

124

AUA2024: A Specialized Masterclass for Single-port Robot-Assisted Surgery

125

Update Series (2024) Lesson 1: A Case-Based Discussion of Priapism Guidelines

126

AUA2023 Take Home Messages Part 5

127

AUA2023 Take Home Messages Part 3

128

AUA2023 Take Home Messages Part 4

129

AUA2023 Take Home Messages Part 2

130

AUA2023 Take Home Messages Part 1

131

PARPi: Management of Adverse Events

132

AUA2023 Journal of Urology Lecture

133

AUA2023 Ramon Guiteras Lecture

134

AUA2023 John Duckett Memorial Lecture

135

AUA2023 John K. Lattimer Lecture

136

Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer

137

The Latest Breakthroughs in Immunotherapy for GU Cancers

138

Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer

139

Novel Imaging for Genitourinary Cancers - Diagnostics and Theranostics

140

Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)

141

Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer

142

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test

143

Infectious Complications Following Prostate Biopsy

144

Germline Testing in GU Cancers – How I Do It

145

Treatment Intensification for Advanced Prostate Cancer

146

PARPi: Precision Medicine in Advanced Prostate Cancer

147

Prostate Cancer Treatment Intensification

148

Update Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline

149

Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer

150

Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects

151

Genetic Testing and Stone Disease

152

Advances in ADT Part II: A Guide for Urologists

153

Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice

154

AUA2023 Medical Student Forum

155

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide

156

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

157

Treatment for Hormone Sensitive Prostate Cancer

158

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men

159

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

160

AUA2023: Upper-Tract Urothelial Cancer Guidelines

161

AUA2023: What the General Urologist Should Know about Care of Transgender Patients

162

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

163

AUA2023: Prostate Cancer Diagnosis

164

Global Advancements in Bladder Cancer

165

AUA2023: Advancing Gender Equity in Urology: Allyship for Men and Advocacy for Women

166

AUA2023: Genetics and Genomics of GU Malignancies: Applications into Your Clinical Practice

167

AUA2023: AUA Guidelines on Advanced Prostate Cancer

168

AUA2023: Diversity, Equity and Inclusion in Urology: What Do We Need to Know

169

AUA2023: The Changing Face of Advanced Prostate Cancer

170

AUA2023: Contemporary Pharmacotherapy for OAB 2023

171

Live from AUA2023: Highlights in BPH

172

Live from AUA2023: Highlights in Advanced Prostate Cancer

173

The Role of PARP Inhibitors in Advanced Prostate Cancer

174

AUA2022: Complications of Vaginal Mesh

175

AUA2022: An Evidence-based Approach to Primary Hypospadias Repair

176

Core Curriculum: Transitional Urology

177

Update Series (2023) Lesson 4: Difficult Foleys and Foley Difficulties

178

AUA2022: Evaluation and Management of Priapism

179

Organizational Leadership: How to Get Involved

180

Modernizing Urology Care: The Current and Future State of Virtual Care in the United States

181

Health Equities and Variations in Advanced Prostate Cancer Care

182

Comorbid Conditions in the Patient with Advanced Prostate Cancer

183

Advances in ADT: A Guide for Urologists and APPs

184

AUA2022 JU Lecture: Engaging Patients: A Challenge to our Care Delivery and Research Priorities

185

AUA2022 Ramon Guiteras Lecture: How to Reach Excellence in Urology: Challenges and Opportunities

186

AUA2022 John Duckett Memorial Lecture: Lifelong Learning, What’s in it for me?

187

AUA2022 John K. Lattimer Lecture: Testosterone, Science and Human Dignity

188

AUA2022 Presidential Address

189

PARP Inhibitors in Advanced Prostate Cancer Care

190

Advancing Women in Urology: Sponsorship and Its Role in Career Advancement in Medicine

191

Addressing Disparities and Variations in Care in GU Oncology

192

Advancing Women in Urology: Coaching and Self-Advocacy

193

Advancing Women in Urology: Negotiating for Success

194

Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies

195

Advancing Women in Urology: The Importance of Meaningful Mentorship

196

Urothelial Carcinoma: Advances in Immuno-Oncology

197

Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients

198

Novel Imaging for Genitourinary Cancers

199

Systemic Therapies for mHSPC and Castrate Resistant Prostate Cancer

200

Update Series (2022) Lesson 7: Management of BPH in Men >80 Years

201

Application of the Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline in Clinical Practice

202

Negotiating Skills 101: Key Steps To Becoming A Good Negotiator

203

Primary Palliative Care in Urology

204

Core Curriculum: Stress Urinary Incontinence Surgery (Female)

205

Cultural Barriers for Ethnic Minorities

206

Core Curriculum: Geriatric Oncology

207

Update Series: Asymptomatic Bacteriuria, Atypical Urinary Tract Infection & the Urinary Microbiome

208

Core Curriculum: GU Cancer Survivorship

209

Advancing Equitable Opportunities for Recruitment of Diverse Patients to Clinical Trials

210

Core Curriculum: Urolithiasis – Surgical Management

211

Core Curriculum: Feminizing and Masculinizing Genital Gender Affirming Surgery

212

AUA2022: Diagnosis And Management Of Localized, Locally Advanced And Advanced Kidney Cancer

213

AUA2022: Operationalizing Checkpoint Inhibitors In Urologic Practice

214

Financial Toxicity as Drugs Move Earlier into Treatment Paradigm

215

AUA2022: Incorporating Genomic Testing For Prostate Cancer Into Your Practice

216

AUA2022: Refractory Overactive Bladder: How to Select 3rd-Line Therapies and Optimize Outcomes

217

AUA2022: Bladder Cancer Treatment Dilemmas: The Cases You Face and What To Do about Them

218

AUA2022: Genetic Testing in Prostate Cancer Webcast

219

Surgical Implications For LGBTQ Patients

220

AUA2022: Surgical & Medical Management of High-Risk Renal Cell Carcinoma

221

AUA2022: Contemporary Pharmacotherapy for OAB 2022

222

Controversies, Confusion, and the Future of Urologic Post-Operative Opioid Prescribing Strategies

223

AUA2022: Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach

224

AUA2022 : The Changing Face of Advanced Prostate Cancer 2022

225

Update Series: AUA/ASRM Infertility Guideline Critique

226

AUA2022: Diversity Equity and Inclusion in Urology: What Do We Need to Know?

227

AUA2022: Should I Order a PET Scan?

228

Live from AUA2022: Highlights in BPH

229

Live from AUA2022: Highlights in Advanced Prostate Cancer

230

Live from AUA2022: Highlights in Overactive Bladder

231

Publishing Ethics

232

Publishing Ethics

233

Adolescent and Young Adult (AYA) Oncology Focusing on Translocation RCC

234

Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP Inhibitors

235

New Minimally Invasive BPH Treatment Options

236

Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy

237

Update Series: Conscious Sedation in the Urology Office

238

Prostate Biopsy: The Transperineal vs. Transrectal Debate

239

AUA2021 State-Of-The-Art Lecture First & Second Line Therapy In Advanced & Metastatic Bladder Cancer

240

AUA2021 State-Of-The-Art Lecture: Penile Fracture Causes And Management

241

AUA2021 Panel Discussion: The Future Of Urologic Oncology

242

AUA2021 State-Of-The-Art Lecture: Robotic Ureteroscopy

243

AUA2021 Panel Discussion: Artificial Intelligence Applications In Urology

244

AUA2021 State-Of-The-Art Lecture: Pain Management In FPMRS Surgery

245

AUA2021 Panel Discussion: COVID And Sexual Medicine

246

AUA2021 John Duckett Memorial Lecture: Nephron Sparing Surgery In The Management Of Wilms Tumor

247

AUA2021 Journal Of Urology Lecture - The Promises And Pitfalls Of Large Database Studies

248

AUA2021 Ramon Guiteras Lecture - Three Decades Of Bladder Cancer Treatment: Progress And Promise

249

AUA2021 John K. Lattimer Lecture - Kidney Stones: Is Prevention Possible?

250

Testis Cancer – Apply the Guidelines to Clinical Practice

251

How to Safely and Properly Administer Immunotherapies

252

Management of Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies

253

Peer-Reviewed Guidance on How to Manage Immune-Related Adverse Events & Toxicities

254

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Update

255

How Can We Improve SDM A Prostate Cancer Survivor’s Perspective

256

Novel Imaging for High Risk Prostate Cancer

257

Evolving Landscape of Androgen Deprivation Therapy in Advanced Prostate Cancer

258

Identification And Management Of Comorbid Conditions In The Patient With Advanced Prostate Cancer

259

Case Based Discussion: Role of Genetic Testing and End of Life Care

260

Optimizing the Treatment of Complicated UTIs

261

Case Based Discussion: Early M1 CRPC & Advanced M1 CRPC

262

Advances in Immuno-Oncology in Urothelial Carcinoma

263

Case Based Discussion: BCR and Novel Pet Imaging & M0 CRPC

264

Understanding Intrarenal Pressure

265

Live from AUA2021: Highlights in Overactive Bladder (2021)

266

Live from AUA2021: Highlights in Advanced Prostate Cancer (2021)

267

NMIBC Guidelines

268

Improving Racial Disparities in Treatment Outcomes Podcast

269

Urolithiasis: Metabolic Evaluation and Medical Management

270

Optimizing Pre-Operative Care for Patients Undergoing Urologic Surgery

271

Reducing Opioid Exposure in the Perioperative Setting

272

An Overview of PARPi & Adverse Event Management

273

Genomic Testing in Prostate Cancer

274

Insight into Race, SDM and the Impact on Access to Quality Care Podcast

275

Surgical Management Of BPH

276

Genetic Testing in Bladder Cancer

277

AUA2021 Kick Off Weekend: Contemporary Pharmacotherapy for OAB 2021

278

AUA2021 Kick Off Weekend: Chemotherapy and Immunotherapy for the Urologist and APP

279

AUA2021 Kick Off Weekend: Trimodality Therapy for Management of Muscle Invasive Bladder Cancer

280

AUA2021 Kick Off Weekend: Diagnosis & Management of Localized & Advanced Kidney Cancer

281

AUA2021 Kick Off Weekend: Incorporating Genomic Testing For Prostate Cancer into Your Practice

282

Diversity In Urology: Initiatives And Opportunities

283

How to Manage a 65 Year Old Man with Bothersome LUTS and Underactive Bladder

284

PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The Community

285

Multidisciplinary Discussion On Fertility, Hypogonadism & Sexual Function For Testis Cancer Patients

286

PARP Inhibitors: Assessing the Clinical Trial Landscape

287

Controversies In Urology - Robotic Kidney Transplantation

288

Panel Discussion - Infection And Urologic Implants

289

PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape

290

Metastatic Hormone Sensitive Prostate Cancer - Expert Guidance For Urologists

291

Impacts of COVID-19 on Urology Training and Education

292

Crossfire In Urology - Robotic Reconstruction

293

Adjuvant Treatment In Bladder Cancer

294

AUA Guidelines Case - Based Panel Stress Urinary Incontinence

295

Panel Discussion - Peyronie's Disease Management

296

Pain Management In Urologic Surgery

297

Bulbar Urethral Strictures 101 - A Review Of The Guidelines And Basic Management Options

298

Update Series - Dusting Vs Extraction Strategies During Ureteroscopy

299

GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For RCC

300

GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

301

Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docataxel Chemotherapy

302

Case-Based Discussion: Early M1 CRPC Management and Advanced M1 CRPC

303

Case-Based Discussion: BCR and mHSPC & M0 CRPC

304

GU Podcast (2020): Genetic Testing And Personalized Medicine In Prostate Cancer

305

GU Podcast (2020): Addressing Disparities in Prostate Cancer Care

306

GU Podcast (2020): Chemo-ablation Of Upper-Tract Urothelial Carcinoma

307

GU Podcast (2020): Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline: Part 2

308

GU Podcast (2020): Targeted Therapies and Integration with Surgical Management of RCC

309

GU Podcast (2020): Immune Checkpoint Inhibitors In RCC

310

GU Podcast (2020): The Expanding Role Of Immune Checkpoint Inhibitors In MIBC And NMIBC

311

GU Podcast (2020): Advanced Prostate Cancer - AUA ASTRO SUO Guideline Podcast Part 1

312

Summer School - Urolithiasis Metabolic Evaluation & Medical Treatment Mixdown

313

Summer School: 2020 Guideline - BPH

314

Genetic Testing in Prostate Cancer: Considerations for Urologists and Their Patients

315

NIDDK Urologic Diseases In America Report - Urinary Stone Disease

316

Summer School: Controversies In Surgical Stone Management - A Case-Based Instructional Course

317

Summer School: Understanding The Evidence New Technologies For Treating BPH & LUTS 2020

318

Summer School : AUA 2020 Guideline Disorders Of Ejaculation

319

Summer School: Testis Cancer - Current Concepts And Controversies

320

Medical Student Curriculum Committee: Optimizing Interaction With Urology Remotely

321

Summer School: What General Urologists Can Do To Evaluate & Successfully Treat Male Infertility

322

Summer School: Current Urologic Management Of Female Sexual Dysfunction

323

Summer School: Recurrent UTIs In Women - Ask The Guideline

324

NIDDK Urologic Diseases In America Episode 3 - Benign Prostatic Hyperplasia

325

Summer School: Interstitial Cystitis/Bladder Pain Syndrome: Current Diagnosis and Management

326

Summer School: Surgical & Medical Management of Stones Guidelines Update

327

Chronic Orchialgia - An Algorithm For Successful Treatment

328

Increasing Workplace Diversity - Attracting And Retaining Women And Minority Urologists

329

Kidney Stone Disease: Rare and Challenging Cases

330

NIDDK Urologic Diseases in America Episode 2 - Urinary Incontinence

331

AUA2019 MAPPing The Clinical Implications Of Phenotypes And Clusters Mixdown

332

2020 AUA MIPS Reporting Webinar

333

COVID-19: Telemedicine with Dr. Eugene Rhee and Elective Surgery with Dr. Chris Gonzalez

334

AUA2019 Panel Discussion - New Technologies For Diagnosing UTIs

335

NIDDK Urologic Diseases In America Intro

336

AUA2019 State - Of - The - Art Lecture STDs And The CDC

337

Get The Facts : AUA/SUFU Diagnosis and Treatment Of Non-Neurogenic OAB in Adults Guideline Update

338

AUA2019 Crossfire: Controversies in Urology: Ureteral Reimplantation should be Robotic

339

AUA2019 Crossfire Controversies In Urology Primary Bulbar Stricture DVIU Is What To Do

340

Rotating On The Urology Service Facts And Strategy For Medical Students

341

2019 Presidential Address: Urologic Research: Why is it So Important to Us

342

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

343

AUA2017 Presidential Address: Urology: A Personal Perspective

344

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

345

Targeted Therapies In Renal Cell Carcinoma

346

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

347

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

348

Adjuvant Therapy in Renal Cell Carcinoma

349

Comorbidities in Advanced Prostate Cancer

350

Genetic Testing in Prostate Cancer

351

Chemo-ablation of Upper-Tract Urothelial Carcinoma

352

AUA SIU Symposium Therapeutic Advances In Immuno - Oncology

353

Immune Checkpoint Inhibitors In Renal Cell Carcinoma

354

AUA2019 Take Home Messages - Female Urology And Incontinence - Reconstruction

355

Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

356

The Role of Immune Checkpoint Inhibitors in Bladder Cancer

357

Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)

358

Update Series v38l1 Diagnosis And Management Of Pheochromocytoma

359

Clinical Investigations in the Treatment of Urothelial Carcinoma

360

AUA2019 Take Home Messages Pediatrics

361

AUA2019 Take Home Messages Infertility Andrology - Sexual Dysfunction Mixdown

362

AUA2019 Take Home Messages - Endourology And Transplantation

363

AUA2019 Take Home Messages - Basic Sciences

364

Second Opinion Cases Ask The Guidelines! Recurrent Urinary Tract Infection

365

AUA2019 072IC Management Of NMIBC - Practical Solutions For Common Problems

366

Manipulating The Androgen Axis | Radionuclide Therapy And Bone Health

367

AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC

368

Setting Up a Clinic In The Community Setting | The Role Of Chemotherapy Treatment

369

AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment

370

Genetic Testing in Advanced Prostate Cancer and Initial Management of Biochemical Recurrence

371

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

372

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

373

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

374

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

375

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

376

AUA2019 013IC Genetic Testing In Prostate Cancer

377

Live From AUA2019 Management Of Advanced And Metastatic Urothelial Carcinoma

378

Live From AUA2019 Management Of Non - Muscle Invasive Urothelial Carcinoma

379

Medical Student Webinar: Urologic Care within Transgender Medicine: Overview of Core Knowledge

380

Framing Pragmatic Strategies To Reduce Mortality From Urothelial Cancer

381

Successful Utilization of Advanced Practice Providers in Urology Practice

382

Court is in Session: Benign: Opioid overdose in patient with chronic flank pain

383

AUA2018 Second Opinion Cases (ask the Guidelines!): Benign Prostatic Hyperplasia (BPH)

384

AUA2018 Second Opinion Cases Testosterone Deficiency

385

AUA2018 Second Opinion Cases Erectile Dysfunction

386

AUA2018 Take Home Messages Bladder Cancer - Basic Science Malignant

387

AUA2018 Take Home Messages Kidney Cancer & Transplantation

388

AUA2018 Take Home Messages Female Urology Incontinence - QIPS

389

AUA2018 Take Home Messages Prostate Cancer - BPH LUTS

390

AUA2018 Take Home Messages Penile Urethral Cancer - Outcomes

391

AUA2018 Take Home Messages Minimally Invasive Surgery - Imaging

392

AUA2018 Take Home Messages Pediatrics plus Highlights From SPU and Journal of Urology

393

Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)

394

Immuno-Oncology: A Focus on Prostate Cancer

395

AUA2018 Residents Forum - The Evolving Practice Of Urology

396

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

397

Immuno-Oncology: A Focus on Kidney Cancer

398

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

399

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

400

Immuno-Oncology: A Focus on Bladder Cancer

401

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

402

Incorporating New IO Therapies - Managing Patient Side Effects

403

Immuno - Oncoloy: A New Class Of Drugs

404

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

405

Incorporating New IO Therapies - Biomarkers

406

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

407

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

408

AUA2018 Take Home Messages - Endourology Stones - Infection Inflammation

409

Emerging Treatment Options For Non - Metastatic CRPC Sept 2018

410

Match Or Mismatch Presented by National Medical Student Education Committee

411

Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines

412

AUA2018 Take Home Messages Basic Sciences - Trauma

413

The Changing Landscape of Advanced Prostate Cancer Management: What You Need to Know

414

AUA2018 043IC - Novel Agents and Concepts in the Management of Hormone Naïve

415

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

416

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

417

AUA2018 063IC - Prostate Cancer Update

418

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

419

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

420

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

421

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

422

Focal Therapy Interview with John W. Davis, MD, FACS

423

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

424

Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)

425

AUA2018 074IC - AUA CRPC Guidelines

426

AUA2018 Contemporary Pharmacotherapy for OAB

427

Minimally Invasive Treatment Of BPH

428

Update on Medical and Surgical Management of Advanced Testis Cancer

429

AUA2017 Court is in Session: Sepsis after Mini PNCL

430

CRPC Sequencing Agents

431

AUA CRPC Guidlines Overview

432

AUA2017 Court is in Session: Myocardial Infarction on Androgren Replacement Therapy

433

AUA2017: Court is in Session: Colostomy after Robotic Prostatectomy

434

AUA2017 Take Home Messages: Bladder Cancer - Transplantation - Female Urology

435

AUA2017 Take Home Messages: BPH/LUTS - Minimally Invasive Surgery - Quality

436

AUA2017 Take Home Messages: Pediatrics | Penile/Urethral Cancer | Kidney Cancer

437

AUA2017 Take Home Messages: Infertility/Andrology | Outcomes | Sexual Dysfunction

438

AUA2017 Take Home Messages: Prostate Cancer, Basic Sciences, and Trauma/Reconstruction

439

Bladder Cancer Immunotherapy Series: Complex Patient Cases

440

PSA Screening changes and USPSTF Recommendations

441

Bladder Cancer Immunotherapy Series: AUA Guideline

442

Low Testosterone

443

SUFU Clinical Care Pathway

444

Bladder Cancer Immunotherapy Series: Immunotherapy: From Research to Practice #1

445

Core Curriculum Video Abstract Request

446

Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

447

Transgender; What Every Urologist Should Know

448

AUA Choosing Wisely

449

Shared Decision Making

450

CRPC 2016

451

Endourology

452

Female Sexual Dysfunction